OABI
OmniAb (OABI)
$74
About OmniAb (OABI)
OmniAb, Inc. operates as a drug discovery company. The firm focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.
Details
Daily high
$2.80
Daily low
$2.35
Price at open
$2.35
52 Week High
$2.80
52 Week Low
$1.30
Market cap
324.7M
Dividend yield
0.00%
Volume
935,190
Avg. volume
402,782
P/E ratio
-4.82
OmniAb News
Details
Daily high
$2.80
Daily low
$2.35
Price at open
$2.35
52 Week High
$2.80
52 Week Low
$1.30
Market cap
324.7M
Dividend yield
0.00%
Volume
935,190
Avg. volume
402,782
P/E ratio
-4.82